The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Madrigal Pharmaceuticals, Inc(NASDAQ:MDGL) 
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is MGL-3196, a liver-directed selective thyroid hormon...
Website: http://www.madrigalpharma.com
Founded: 2011
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
Madrigal Pharmaceuticals Days Payable Outstanding ttm (DPO)
Madrigal Pharmaceuticals Op Cashflow Per Share ttm
Madrigal Pharmaceuticals Free Cashflow Per Share ttm
Madrigal Pharmaceuticals Cash Per Share ttm
Madrigal Pharmaceuticals P/S ratio ttm
Madrigal Pharmaceuticals (GAAP) P/E ratio ttm
Madrigal Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.